EPISODE · Jul 20, 2020 · 13 MIN
A homegrown vaccine?
As results of the first human trials of Oxford University vaccine show immune reaction produced without any serious adverse reactions, virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss why she thinks the results are ‘very, very encouraging’, whether a vaccine is ‘one size fits all’ and how virus mutation could affect crucial immunology research.Read more about the potential coronavirus treatment from Synairgen: https://bit.ly/2WG5FzrRead more about Test and Trace privacy allegations: https://bit.ly/2WEPdPSRead more about French face masks: https://bit.ly/3fMPSq6For 30 days' free access to The Telegraph: www.telegraph.co.uk/audioEmail: [email protected] Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
As results of the first human trials of Oxford University vaccine show immune reaction produced without any serious adverse reactions, virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss why she thinks the results are ‘very, very encouraging’, whether a vaccine is ‘one size fits all’ and how virus mutation could affect crucial immunology research.Read more about the potential coronavirus treatment from Synairgen: https://bit.ly/2WG5FzrRead more about Test and Trace privacy allegations: https://bit.ly/2WEPdPSRead more about French face masks: https://bit.ly/3fMPSq6For 30 days' free access to The Telegraph: www.telegraph.co.uk/audioEmail: [email protected] Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
A homegrown vaccine?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m